Literature DB >> 23807195

Eavesdropping on PTM cross-talk through serial enrichment.

Kristofor Webb1, Eric J Bennett.   

Abstract

Mesh:

Substances:

Year:  2013        PMID: 23807195     DOI: 10.1038/nmeth.2526

Source DB:  PubMed          Journal:  Nat Methods        ISSN: 1548-7091            Impact factor:   28.547


× No keyword cloud information.
  10 in total

1.  Methods for quantification of in vivo changes in protein ubiquitination following proteasome and deubiquitinase inhibition.

Authors:  Namrata D Udeshi; D R Mani; Thomas Eisenhaure; Philipp Mertins; Jacob D Jaffe; Karl R Clauser; Nir Hacohen; Steven A Carr
Journal:  Mol Cell Proteomics       Date:  2012-04-14       Impact factor: 5.911

Review 2.  The regulatory crosstalk between kinases and proteases in cancer.

Authors:  Carlos López-Otín; Tony Hunter
Journal:  Nat Rev Cancer       Date:  2010-03-19       Impact factor: 60.716

3.  DNMT1 stability is regulated by proteins coordinating deubiquitination and acetylation-driven ubiquitination.

Authors:  Zhanwen Du; Jing Song; Yong Wang; Yiqing Zhao; Kishore Guda; Shuming Yang; Hung-Ying Kao; Yan Xu; Joseph Willis; Sanford D Markowitz; David Sedwick; Robert M Ewing; Zhenghe Wang
Journal:  Sci Signal       Date:  2010-11-02       Impact factor: 8.192

Review 4.  Analysis of intact protein isoforms by mass spectrometry.

Authors:  Jeremiah D Tipton; John C Tran; Adam D Catherman; Dorothy R Ahlf; Kenneth R Durbin; Neil L Kelleher
Journal:  J Biol Chem       Date:  2011-06-01       Impact factor: 5.157

Review 5.  Next-generation proteomics: towards an integrative view of proteome dynamics.

Authors:  A F Maarten Altelaar; Javier Munoz; Albert J R Heck
Journal:  Nat Rev Genet       Date:  2012-12-04       Impact factor: 53.242

6.  Global analysis of phosphorylation and ubiquitylation cross-talk in protein degradation.

Authors:  Danielle L Swaney; Pedro Beltrao; Lea Starita; Ailan Guo; John Rush; Stanley Fields; Nevan J Krogan; Judit Villén
Journal:  Nat Methods       Date:  2013-06-09       Impact factor: 28.547

7.  Integrated proteomic analysis of post-translational modifications by serial enrichment.

Authors:  Philipp Mertins; Jana W Qiao; Jinal Patel; Namrata D Udeshi; Karl R Clauser; D R Mani; Michael W Burgess; Michael A Gillette; Jacob D Jaffe; Steven A Carr
Journal:  Nat Methods       Date:  2013-06-09       Impact factor: 28.547

8.  Systematic and quantitative assessment of the ubiquitin-modified proteome.

Authors:  Woong Kim; Eric J Bennett; Edward L Huttlin; Ailan Guo; Jing Li; Anthony Possemato; Mathew E Sowa; Ramin Rad; John Rush; Michael J Comb; J Wade Harper; Steven P Gygi
Journal:  Mol Cell       Date:  2011-09-08       Impact factor: 17.970

Review 9.  Emerging regulatory mechanisms in ubiquitin-dependent cell cycle control.

Authors:  Annamaria Mocciaro; Michael Rape
Journal:  J Cell Sci       Date:  2012-01-15       Impact factor: 5.285

10.  A proteome-wide, quantitative survey of in vivo ubiquitylation sites reveals widespread regulatory roles.

Authors:  Sebastian A Wagner; Petra Beli; Brian T Weinert; Michael L Nielsen; Jürgen Cox; Matthias Mann; Chunaram Choudhary
Journal:  Mol Cell Proteomics       Date:  2011-09-01       Impact factor: 5.911

  10 in total
  4 in total

Review 1.  Quantitative proteomic analysis of histone modifications.

Authors:  He Huang; Shu Lin; Benjamin A Garcia; Yingming Zhao
Journal:  Chem Rev       Date:  2015-02-17       Impact factor: 60.622

Review 2.  The role of ubiquitination in tumorigenesis and targeted drug discovery.

Authors:  Lu Deng; Tong Meng; Lei Chen; Wenyi Wei; Ping Wang
Journal:  Signal Transduct Target Ther       Date:  2020-02-29

Review 3.  Fourier-transform ion cyclotron resonance mass spectrometry for characterizing proteoforms.

Authors:  Trisha Tucholski; Ying Ge
Journal:  Mass Spectrom Rev       Date:  2020-09-07       Impact factor: 10.946

Review 4.  The role of ubiquitination in tumorigenesis and targeted drug discovery.

Authors:  Lu Deng; Tong Meng; Lei Chen; Wenyi Wei; Ping Wang
Journal:  Signal Transduct Target Ther       Date:  2020-02-29
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.